- Home
- JBIO vs FTF Comparison
JBIO vs FTF Comparison
Compare JBIO & FTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JBIO
- FTF
- Stock Information
- Founded
- JBIO 2024
- FTF 2003
- Country
- JBIO United States
- FTF United States
- Employees
- JBIO N/A
- FTF N/A
- Industry
- JBIO
- FTF Finance/Investors Services
- Sector
- JBIO
- FTF Finance
- Exchange
- JBIO NYSE
- FTF Nasdaq
- Market Cap
- JBIO 290.1M
- FTF 256.8M
- IPO Year
- JBIO N/A
- FTF N/A
- Fundamental
- Price
- JBIO $8.28
- FTF $6.39
- Analyst Decision
- JBIO Strong Buy
- FTF
- Analyst Count
- JBIO 2
- FTF 0
- Target Price
- JBIO $15.50
- FTF N/A
- AVG Volume (30 Days)
- JBIO 397.1K
- FTF 153.9K
- Earning Date
- JBIO 08-05-2025
- FTF 01-01-0001
- Dividend Yield
- JBIO N/A
- FTF 11.45%
- EPS Growth
- JBIO N/A
- FTF N/A
- EPS
- JBIO N/A
- FTF N/A
- Revenue
- JBIO N/A
- FTF N/A
- Revenue This Year
- JBIO N/A
- FTF N/A
- Revenue Next Year
- JBIO N/A
- FTF N/A
- P/E Ratio
- JBIO N/A
- FTF N/A
- Revenue Growth
- JBIO N/A
- FTF N/A
- 52 Week Low
- JBIO $1.61
- FTF $5.76
- 52 Week High
- JBIO $13.50
- FTF $6.56
- Technical
- Relative Strength Index (RSI)
- JBIO N/A
- FTF 45.90
- Support Level
- JBIO N/A
- FTF $6.35
- Resistance Level
- JBIO N/A
- FTF $6.41
- Average True Range (ATR)
- JBIO 0.00
- FTF 0.06
- MACD
- JBIO 0.00
- FTF -0.01
- Stochastic Oscillator
- JBIO 0.00
- FTF 33.33
About JBIO JADE BIOSCIENCES INC
Jade Biosciences Inc is focused on developing therapies to address critical unmet needs in autoimmune diseases. Its asset, JADE-001, will target the anti-A PRoliferation-Inducing Ligand (APRIL) pathway for immunoglobulin A (IgA) nephropathy, with Investigational New Drug Application-enabling studies underway and initiation of a first-in-human trial. Jade's pipeline also includes two undisclosed optimized antibody discovery programs, JADE-002 and JADE-003, currently in preclinical development. Jade was launched based on assets licensed from Paragon Therapeutics, an antibody discovery engine founded by Fairmount.
About FTF Franklin Limited Duration Income Trust of Beneficial Interest
Franklin Limited Duration Income Trust is a closed-end investment company based in the United States. It conducts its investment to provide high, current income, with a secondary objective of capital appreciation. To align with its investment objective is to invest in a diversified mix of fixed-income securities. Its portfolio is dominated by considerable investments in high-yield corporate bonds while touching upon other avenues such as senior secured floating rate corporate loans, mortgage-backed securities, commercial mortgage-backed securities, asset-backed securities, common stocks, and other short-term investments.